Truveta

Truveta

Private
Bellevue, WashingtonHealthcare & Life Scienceshttps://www.truveta.com

Last Round

Series C

1/13/2025

Est. Valuation

$1B

Total Funding Raised

$520M

Company Overview

Truveta is a healthcare technology company that offers a health data platform to aggregate and de-identify data from various healthcare systems, providing valuable medical insights to accelerate research and support informed decision-making for families and clinicians.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Clinical Trials, Medical AI, Drug Discovery, EHR & EMR

Business Model

B2B

Customer Profile

Data as a Service, Subscription SaaS, Government Contracts, Usage-Based SaaS

AI Layer

Infrastructure

Keywords

real-world dataRWDhealth data platformEHR datahealthcare analyticsreal-world evidenceRWEde-identified patient datadata consortiumgenetic databasehealth data lakeclinical trial optimizationpatient outcomes researchData as a ServiceDaaSregulatory-grade datamedical AIdata normalization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Truveta Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Truveta Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series C1/13/2025
Series B11/9/2021
Series A Extension9/29/2021
Series A7/13/2021

Key People

Founding team and executive leadership

Jay Nanduri

Chief Technical Officer Co-Founder

Founding Team

Ryan Ahern

Chief Medical Officer Co-founder

Founding Team

Terry Myerson

CEO and Co-founder

Founding Team

Truveta Investors

Notable investors and investment history

InvestorRounds
Novant HealthSeries A
Ochsner VenturesSeries B
Catholic Health InitiativesSeries A, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 5, 2026

    Intelligence Platform (IPA) is an agentic AI system in development.

  • Mar 5, 2026

    EHR database now includes data from over 125 million patients.

Truveta Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Truveta Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Truveta's valuation, stock price, and market status.

Firmographic Details

HeadquartersBellevue, Washington
Employee Range415
Year Founded2020
Last Funding1/13/2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.